EUVIMEDEUVIMED entdecken
Übersichtsarbeit

What common biomarkers characterize a triple-negative profile in breast cancer?

I Kallel, M Rebaï, A Khabir, A Rebaï

Pathologie Biologie · 2015-09 · 63 (4-5) · 224-229

DOI: 10.1016/j.patbio.2015.07.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathologie Biologie, 2015-09. Verfasst von I Kallel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Cellular Diagnosis Processes, Centre of Biotechnology of Sfax, University of Sfax, Route Sidi Mansour, Po Box 1177, 3018 Sfax, Tunisia;…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 100 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancers are not a homogeneous subgroup. There is substantial intra-subgroup diversity in tumor biology, prognosis and treatment sensitivity. Then, these triple-negative phenotype (TNP) groups, having specific features, can be again divided into subclasses based on an added immunohistochemical markers. The challenge in treating TNP breast cancers is that they are not responsive to antiestrogens or trastuzumab secondary to negative receptor status, and as a result have a poor prognosis. Therefore, the presence or absence of supplementary markers could help predict which therapies are best suited for patients based on the pattern that their disease markers show. In this review, we will recapitulate the major supplementary biomarkers related to triple-negative breast cancer, which could give new therapeutic options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsBRCA1 ProteinBiomarkers, TumorCarcinoma, Ductal, BreastCarcinoma, LobularCyclin-Dependent Kinase Inhibitor p16ErbB ReceptorsEthnicityFemaleGenes, BRCA1Genes, erbB-1Genes, p53HumansHyaluronan ReceptorsMolecular Targeted TherapyNeoplasm ProteinsProto-Oncogene Proteins c-bcl-2Receptors, AndrogenSensitivity and SpecificityTriple Negative Breast Neoplasms

Stichwörter der Autor:innen

BiomarkersBiomarqueursBreast cancerCancer du seinProfil triple négatifPrognosisPronosticTriple-negative profile

Substanzen

Antineoplastic AgentsBRCA1 ProteinBiomarkers, TumorCD44 protein, humanCyclin-Dependent Kinase Inhibitor p16Hyaluronan ReceptorsNeoplasm ProteinsProto-Oncogene Proteins c-bcl-2Receptors, AndrogenTP53 protein, human

Autor:innen und Institutionen

  • Molecular and Cellular Diagnosis Processes, Centre of Biotechnology of Sfax, University of Sfax, Route Sidi Mansour, Po Box 1177, 3018 Sfax, Tunisia; Department of Pathology, Habib Bourguiba hospital, Sfax, Tunisia.
  • Molecular and Cellular Diagnosis Processes, Centre of Biotechnology of Sfax, University of Sfax, Route Sidi Mansour, Po Box 1177, 3018 Sfax, Tunisia.
  • Department of Pathology, Habib Bourguiba hospital, Sfax, Tunisia.
  • Molecular and Cellular Diagnosis Processes, Centre of Biotechnology of Sfax, University of Sfax, Route Sidi Mansour, Po Box 1177, 3018 Sfax, Tunisia. Electronic address: ahmed.rebai@cbs.rnrt.tn.

Zitieren

APA

Kallel, I., Rebaï, M., Khabir, A., & Rebaï, A. (2015). What common biomarkers characterize a triple-negative profile in breast cancer?. Pathologie Biologie, 63(4-5), 224-229. https://doi.org/10.1016/j.patbio.2015.07.005

Vancouver

Kallel I, Rebaï M, Khabir A, Rebaï A. What common biomarkers characterize a triple-negative profile in breast cancer?. Pathologie Biologie. 2015;63(4-5):224-229. doi:10.1016/j.patbio.2015.07.005

BibTeX
@article{Kallel2015,
  author = {Kallel, I and Rebaï, M and Khabir, A and Rebaï, A},
  title = {What common biomarkers characterize a triple-negative profile in breast cancer?},
  journal = {Pathologie Biologie},
  year = {2015},
  volume = {63},
  number = {4-5},
  pages = {224--229},
  doi = {10.1016/j.patbio.2015.07.005}
}
Kostenlos starten →